We’ve already reported on the retraction of a paper in a business ethics journal for plagiarism. Yes, plagiarism in an ethics journal. But it turns out there’s at least one more case of exactly the same thing, albeit in a different business ethics journal. Here’s the notice from the Journal of Business Ethics:
Coding errors in a database maintained by Pfizer have led authors to retract two heart biomarker papers in the Journal of the American College of Cardiology. The two notices, for “Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers” and “Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New … Continue reading Pfizer database errors cause two voluminous retractions for JACC statin-biomarker papers
A group of researchers from Shangdong, China, has retracted their 2011 paper in the Journal of Molecular Medicine on the heart-protective properties of a substance in ginseng because the article contained dodgy figures. The article, “Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction,” purported to show that ginsenoside:
Is this the new business ethics? In January, we reported on a paper retracted from the Journal of Business Ethics for duplication. That earned the author a five-year publishing ban. This week, we learned of a case of plagiarism in another journal in the field, the Journal of Academic and Business Ethics. Here’s an email … Continue reading Oh, the irony: Business ethics journal paper retracted for plagiarism
The Journal of Maternal-Fetal & Neonatal Medicine has retracted a 2008 article on smoking cessation by a group from Sweden which they had published not many months before in a different journal. The retracted paper was titled “Quitting smoking is perceived to have an effect on somatic health among pregnant and non-pregnant women.” The authors, … Continue reading Smoking cessation paper pulled for “almost word-for-word” similarity to authors’ previous work
Noriyuki Takai, a gynecologic cancer researcher at Oita University in Japan who retracted three papers last October, has four more retractions, these in Cancer Letters. All but one of the notices reads as follows:
Hiroaki Matsubara, a leading Japanese cardiology researcher who has had three papers retracted and another five subject to expressions of concern, has resigned from Kyoto Prefectural University, according to local media. Mainichi Shimbun reports — according to our roughest of (Google) translations — that Kyoto Prefectural University accepted Matsubara’s resignation following an investigation. That investigation … Continue reading After three retractions, five expressions of concern, cardiologist Matsubara resigns post
Hip International has retracted a case study for duplication. (We apologize for the partial duplication of a headline for an earlier post about this journal, which told readers that “Similar cases will be referred to retractionwatch.”) The article was titled “Chronic intoxication with cobalt following revision total hip arthroplasty,” and it appeared online ahead of … Continue reading Hip, hip, retract! Cobalt poisoning case study pulled as duplicate
A German professor who claims to have developed “a self-consistent field theory which is used to derive at all known interactions of the potential vortex” will have at least two papers retracted, thanks to the scrutiny of a concerned economist. The first retraction has already appeared, in DNA and Cell Biology, for a paper by … Continue reading “Way out there” paper claiming to merge physics and biology retracted
Plagiarism and duplication might involve the same act — the misuse of text and/or data — but they are different species. Take it from Eldon Smith, who as editor of the Canadian Journal of Cardiology defined the two acts of misconduct for his readers: Plagiarism is the appropriation of another person’s ideas, processes, results or … Continue reading Retraction Watch, Noah Webster style, cardiology edition